MELONI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 5.732
AS - Asia 1.467
EU - Europa 976
SA - Sud America 314
AF - Africa 27
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.527
Nazione #
US - Stati Uniti d'America 5.678
SG - Singapore 723
IT - Italia 300
BR - Brasile 253
CN - Cina 240
RU - Federazione Russa 168
HK - Hong Kong 155
VN - Vietnam 152
IE - Irlanda 90
FI - Finlandia 79
DE - Germania 71
JP - Giappone 64
FR - Francia 63
GB - Regno Unito 53
UA - Ucraina 44
IN - India 29
NL - Olanda 29
CA - Canada 26
AR - Argentina 25
PL - Polonia 22
MX - Messico 21
ID - Indonesia 15
KR - Corea 15
SE - Svezia 14
EC - Ecuador 13
BD - Bangladesh 12
ES - Italia 11
AU - Australia 8
TR - Turchia 8
CO - Colombia 7
EG - Egitto 6
MY - Malesia 6
PH - Filippine 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
IQ - Iraq 5
IR - Iran 5
LT - Lituania 5
SA - Arabia Saudita 5
MA - Marocco 4
NG - Nigeria 4
PY - Paraguay 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
CL - Cile 3
NO - Norvegia 3
RO - Romania 3
AM - Armenia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
MD - Moldavia 2
PE - Perù 2
SR - Suriname 2
TW - Taiwan 2
UY - Uruguay 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
KW - Kuwait 1
MV - Maldive 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.527
Città #
Wilmington 1.316
Houston 1.054
Woodbridge 882
Singapore 432
Ashburn 231
San Jose 220
Fairfield 208
Chandler 177
Hong Kong 150
Beijing 119
Seattle 107
Council Bluffs 94
Rome 84
New York 81
Dublin 79
Cambridge 77
Los Angeles 66
Santa Clara 60
Tokyo 57
Helsinki 56
Ho Chi Minh City 55
Ann Arbor 52
Medford 51
Dallas 50
The Dalles 49
Milan 34
Jacksonville 33
North Bergen 30
Hanoi 29
Colorado Springs 27
São Paulo 27
Buffalo 26
Lauterbourg 25
Menlo Park 25
Lawrence 24
Moscow 23
Chicago 20
Munich 19
Warsaw 17
Frankfurt am Main 16
Orem 14
Redondo Beach 14
San Diego 14
London 13
Sarno 13
Shanghai 12
Lappeenranta 10
Palo Alto 10
Rio de Janeiro 10
Toronto 10
Denver 9
Mexico City 9
Nuremberg 9
Phoenix 9
Belo Horizonte 8
Chennai 8
Engelhard 8
Salt Lake City 8
San Francisco 8
Atlanta 7
Da Nang 7
Manchester 7
Miami 7
Monmouth Junction 7
Naples 7
Poplar 7
Stockholm 7
Brooklyn 6
Dearborn 6
Falls Church 6
Jakarta 6
Seoul 6
Turin 6
Boardman 5
Florence 5
Goiânia 5
Guarulhos 5
Haiphong 5
Kuala Lumpur 5
Lahore 5
Raleigh 5
Ankara 4
Biên Hòa 4
Bắc Ninh 4
Charlotte 4
Columbus 4
Guayaquil 4
Hangzhou 4
Las Vegas 4
Melbourne 4
Montreal 4
Pisa 4
Querétaro 4
Quito 4
Roubaix 4
Sterling 4
Suzhou 4
Vienna 4
Volta Redonda 4
Abuja 3
Totale 6.585
Nome #
Alternative techniques for treatment of complex below-the knee arterial occlusions in diabetic patients with critical limb ischemia. 519
A New Natural History of Charcot Foot 454
Limb Salvage in Patients With Diabetes Is Not a Temporary Solution but a Life-Changing Procedure 431
Management of negative pressure wound therapy in the treatment of diabetic foot ulcers 417
Non-healing foot ulcers in diabetic patients: General and local interfering conditions and management options with advanced wound dressings 410
Proton magnetic resonance spectroscopy in the evaluation of patients with acute Charcot neuro-osteoarthropathy 396
High matrix metalloproteinase levels are associated with dermal graft failure in diabetic foot ulcers 376
Below-the-ankle arterial disease severely impairs the outcomes of diabetic patients with ischemic foot ulcers 248
Critical limb ischemia: Current challenges and future prospects 235
Rearfoot Transcutaneous Oximetry is a Useful Tool to Highlight Ischemia of the Heel 223
Physician experts in diabetes are natural team leaders for managing diabetic patients with foot complications. A position statement from the Italian diabetic foot study group 214
Endovascular Distal Plantar Vein Arterialization in Dialysis Patients With No-Option Critical Limb Ischemia and Posterior Tibial Artery Occlusion: A Technique for Limb Salvage in a Challenging Patient Subset 205
Limb Salvage in Diabetic Patients With Ischemic Heel Ulcers 201
Recurrence of Critical Limb Ischemia after Endovascular Intervention in Patients with Diabetic Foot Ulcers 200
Diabetes, Lower-Extremity Amputation, and Death. Diabetes Care 2015;38: 1852-1857 198
Osteomyelitis in diabetic foot: A comprehensive overview 192
The Effectiveness of Negative Pressure Therapy in Diabetic Foot Ulcers with Elevated Protease Activity: A Case Series 183
Peripheral arterial disease in patients with renal-diabetic foot ulcers 183
Procalcitonin Is a Prognostic Marker of Hospital Outcomes in Patients with Critical Limb Ischemia and Diabetic Foot Infection 180
Impact of heart failure and dialysis in the prognosis of diabetic patients with ischemic foot ulcers 178
Letter Regarding “The Prostacyclin Analogue Iloprost as an Early Predictor of Successful Revascularization in Diabetic Patients Affected by Critical Limb Ischemia and Foot Ulcers” 161
Insulin Resistance and Acne: The Role of Metformin as Alternative Therapy in Men 152
Foot Revascularization Avoids Major Amputation in Persons with Diabetes and Ischaemic Foot Ulcers 113
Diabetes and cognitive decline 107
Recent pharmacological options in type 2 diabetes and synergic mechanism in cardiovascular disease 101
Effectiveness of Sucrose Octasulfate Dressing in the Treatment of Neuro-Ischaemic Diabetic Foot Heel Ulcers: A Retrospective Single arm Study 98
Below-the-ankle arterial disease: a new marker of coronary artery disease in patients with diabetes and foot ulcers 96
A multidisciplinary team reduces in-hospital clinical complications and mortality in patients with diabetic foot ulcers 93
Microbiological and Clinical Characteristics of Infected Diabetic Foot Ulcers Managed in a Tertiary Level Diabetic Foot Service 87
Risk Factors for Ulcer Recurrence in Diabetic Patients Managed by an Integrated Foot Care Protocol 87
The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases 85
Hospital Readmission in Patients With Diabetic Foot Ulcers: Prevalence, Causes, and Outcomes 84
Nanomedicine in the Treatment of Diabetes 84
Macrophage Activation and M2 Polarization in Wound Bed of Diabetic Patients Treated by Dermal/Epidermal Substitute Nevelia 82
Peripheral Blood Mononuclear Cells: A New Frontier in the Management of Patients with Diabetes and No-Option Critical Limb Ischaemia 79
Bioactive Glass in a Multi Drug Resistance Osteomyelitis in Diabetic Foot: Case Report 79
Occupational Radiation Exposure and Thyroid Nodules in Healthcare Workers: A Review 79
Surgical treatment of post-menopausal ovarian hyperandrogenism improves glucometabolic profile alongside clinical hirsutism 79
Geographic and Ethnic Inequalities in Diabetes-Related Amputations 79
Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects 78
Effect of a multidisciplinary team approach in patients with diabetic foot ulcers on major adverse limb events (MALEs): systematic review and meta-analysis for the development of the Italian guidelines for the treatment of diabetic foot syndrome 76
Early Treatment of Acute Stage 0/1 Diabetic Charcot Foot Can Avoid Major Amputations at One Year 74
Endovascular treatment of calcific lesions of the common femoral artery using atherectomy device associated with scoring balloon angioplasty in diabetic patients with high “major amputation” risk 74
Effectiveness of fast-track pathway for diabetic foot ulcerations 72
The New Role of SGLT2 Inhibitors in the Management of Heart Failure: Current Evidence and Future Perspective 71
Characteristics and outcome for persons with diabetic foot ulcer and no-option critical limb ischemia 70
Diabetic Foot Osteomyelitis in Patients with and without Peripheral Arterial Disease: Two Different Diseases? 70
The Immune-Centric Revolution in the Diabetic Foot: Monocytes and Lymphocytes Role in Wound Healing and Tissue Regeneration-A Narrative Review 69
The Neuro-Ischaemic Charcot Foot: Prevalence, Characteristics and Severity of Peripheral Arterial Disease in Acute Charcot Neuro-Arthropathy 67
Survival and factors predicting mortality after major and minor lower-extremity amputations among patients with diabetes: a population-based study using health information systems 61
Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis 58
Prevalence, clinical aspects and outcomes in a large cohort of persons with diabetic foot disease: Comparison between neuropathic and ischemic ulcers 58
Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers 54
Response to the letter of Tariq and colleagues on the paper "below‑the‑ankle arterial disease: a new marker of coronary artery disease in patients with diabetes and foot ulcers" 50
From a spark to a flame: the evolution of diabetic foot disease in the last two decades 50
Peripheral Arterial Disease in Diabetic Foot: One Disease with Multiple Patterns 46
Management of diabetic persons with foot ulceration during COVID-19 health care emergency: Effectiveness of a new triage pathway 45
The appropriateness of footwear in diabetic patients observed during a podiatric examination: a prospective observational study 37
The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)—Rationale and Meta-Analysis of Observational Studies 35
Delayed referral of patients with diabetic foot ulcers across Europe: Patterns between primary care and specialised units 33
Correction to: Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects 31
Use of Nevelia Dermal-Epidermal Regenerative Template in the Management of Ischemic Diabetic Foot Postsurgical Wounds 28
Fast-track pathway for diabetic foot ulceration during COVID-19 crisis: A document from International Diabetic Foot Care Group and D-Foot International 13
Totale 8.788
Categoria #
all - tutte 26.846
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.846


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021105 0 0 0 0 0 0 0 0 0 60 30 15
2021/2022275 15 15 27 3 7 27 18 7 19 20 28 89
2022/2023433 27 41 16 46 65 78 42 35 40 4 33 6
2023/2024229 16 5 45 4 15 41 30 5 22 4 10 32
2024/20251.220 39 189 124 76 101 154 85 67 98 108 101 78
2025/20262.658 156 235 353 290 263 96 415 287 309 254 0 0
Totale 8.788